Kim Popovits

Kimberly J.
Popovits is currently Independent Director at 10X Genomics, Inc. since 2020, Independent Director at Kiniksa Pharmaceuticals Ltd. since 2018, Lead Independent Director at Talis Biomedical Corp.
since 2020, Independent Non-Executive Director at Kardigan, Inc. since 2024, Independent Director at Kiniksa Pharmaceuticals International Plc since 2024, and Independent Director at Rhythm Pharmaceuticals, Inc. starting in 2026.
Ms. Popovits also serves as Director at American Clinical Laboratory Association, Personalized Medicine Coalition, California Biomedical Innovation Alliance, Kiniksa Pharmaceuticals Corp., California Life Sciences Association, Genomic Life, Inc., and The Coalition for 21st Century Medicine.
Former roles include Chairman, President & Chief Executive Officer at Genomic Health, Inc. from 2012 to 2019, Vice Chairman at Nuvelo, Inc. from 2005 to 2009, Independent Director at ZS Pharma, Inc. in 2015, Independent Director at MyoKardia, Inc. from 2017 to 2020, Independent Director at EXACT Sciences Corp.
from 2025 to 2026, Senior Vice President-Marketing & Sales at Genentech, Inc. from 2001 to 2002, Director at The Bay Area Bioscience Association, Division Manager-American Critical Care Division at American Hospital Supply Corp., and Division Manager-Southeast Region at American Critical Care Services, Inc.Education includes undergraduate studies at Michigan State University.